Stressful life experiences were correlated with dysregulation of HDAC2 and HDCA5 levels [74,75], and preclinical studies have suggested HDAC inhibitors as a potential therapeutic agent for MDD [76,77]. Here, HDAC2 is linked to major depressive disorder.